Search
for
Sort by
Research 511–540 of 1000+
- Evidence-based approach to cutaneous hyperandrogenism in women
- Granzyme B in Autoimmune Skin Disease
- Advances in Medicalized Hair Loss Solutions: A Review of Current Clinical Practices and Regenerative Medicine-Based Protocols with Focus on Off-Label Injectable Treatments
- Recombinant Human Annexin A5 Ameliorates Localized Scleroderma by Inhibiting the Activation of Fibroblasts and Macrophages
- Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism
- Insights into the Diagnostics and Therapeutics of Alopecia Areata—An Indian Context
- Nails and hair
- Medical treatment of hirsutism
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Application of Scaffold-Based Drug Delivery in Oral Cancer Treatment: A Novel Approach
- Androgenetic alopecia and current methods of treatment.
- Medical Treatment of Hirsutism in Women
- Can Plasma Rich in Growth Factors Be Safe for Parental Use? A Safety Study in the Canine Model
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Treatment with Light-Emitting Diodes of Wavelength 863 nm Delays DMBA/TPA-Induced Skin Tumor Formation and Decreases Proinflammatory Cytokine Levels in ICR Mice
- Apoptosis in Hair and Skin: A Review
- Treatment of acne vulgaris: a literature review / Lečenje običnih akni (acne vulgaris) – pregled literature
- Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems
- Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
- Fundamentals Alopecia and Hair Transplantation
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- Alopecia areata mit gutem Ansprechen auf Tofacitinib
- Retinoids and hair growth
- The gut‐microbiota‐brain axis: Focus on gut steroids
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Microneedle-mediated intelligent combination delivery for hair regeneration: A comprehensive review of technologies, mechanistic evidence, and translational prospects
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia